ConductScience.org, home

Paper40237828

[Diagnosis and drug therapy of chronic rhinosinusitis].

Becker S. HNO, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Diagnosis and drug therapy of chronic rhinosinusitis]. Papers, record 40237828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40237828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Diagnosis and drug therapy of chronic rhinosinusitis].
PubMed
Journal
HNO
PubMed
Year
2025
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-06-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Becker SSven

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
RhinitisMajor topic
SinusitisMajor topic
Humans
Chronic Disease
Evidence-Based Medicine
Rhinosinusitis
Treatment Outcome

Source PubMed

Download CSV of topics

References194

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137203259Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).Allergy2023https://conductscience.org/library/papers/37203259PubMed
235386961Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA.Front Allergy2021https://conductscience.org/library/papers/35386961PubMed
336050129Endotypes of atopic dermatitis and food allergy.J Allergy Clin Immunol2023https://conductscience.org/library/papers/36050129PubMed
439149992Comparative Effectiveness of Dupilumab Versus Sinus Surgery for Chronic Rhinosinusitis With Polyps: Systematic Review and a Meta-Analysis.Am J Rhinol Allergy2024https://conductscience.org/library/papers/39149992PubMed
528651294[IgE and Anti-IgE in Asthma: A Chequered History].Pneumologie2017https://conductscience.org/library/papers/28651294PubMed
69013989Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.J Immunol1997https://conductscience.org/library/papers/9013989PubMed
733271403Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).J Psychosom Res2021https://conductscience.org/library/papers/33271403PubMed
821605125Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study.Allergy2011https://conductscience.org/library/papers/21605125PubMed
936832203The Diagnostic and Prognostic Role of Biomarkers in Chronic Rhinosinusitis.Diagnostics (Basel)2023https://conductscience.org/library/papers/36832203PubMed
1039641626Algorithm for the Management of Primary Diffuse Chronic Rhinosinusitis.Allergy2025https://conductscience.org/library/papers/39641626PubMed
1132498540Histopathologic Influences of Comorbid Smoking Status in Chronic Rhinosinusitis.Am J Rhinol Allergy2020https://conductscience.org/library/papers/32498540PubMed
1216405274Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis.Rhinology2005https://conductscience.org/library/papers/16405274PubMed
1333846604Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?Nat Rev Immunol2021https://conductscience.org/library/papers/33846604PubMed
1438892164Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.Int J Mol Sci2024https://conductscience.org/library/papers/38892164PubMed
1532294933Nasal Epithelial Cells Activated with Alternaria and House Dust Mite Induce Not Only Th2 but Also Th1 Immune Responses.Int J Mol Sci2020https://conductscience.org/library/papers/32294933PubMed
1634592767
Positionspapier: Empfehlungen zur Anwendung von Omalizumab bei chronischer Rhinosinusitis mit Polyposis nasi (CRSwNP) im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der AGs Klinische Immunologie, Allergologie und Umweltmedizin und Rhinologie und Rhinochirurgie der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNOKHC).
Laryngorhinootologie2021https://conductscience.org/library/papers/34592767PubMed
1731908763Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.Clin Transl Allergy2020https://conductscience.org/library/papers/31908763PubMed
1822287332Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review.Int Forum Allergy Rhinol2011https://conductscience.org/library/papers/22287332PubMed
1931220711Mucosal IgE immune responses in respiratory diseases.Curr Opin Pharmacol2019https://conductscience.org/library/papers/31220711PubMed
2027113482Systemic and topical antibiotics for chronic rhinosinusitis.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27113482PubMed

See all 194 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40237828

GET https://conductscience.org/api/papers/v1/40237828/references?page=2